Simvastatin Versus MTA in Pulpotomy of Immature Permanent Molars

Clinical and Digital Radiographic Evaluation of Simvastatin Versus MTA in Pulpotomy of Immature Permanent Vital Molars: A18 Month Randomized Controlled Trial

the study will be done to evaluate the clinical and digital radiographic success of simvastatin versus MTA in pulpotomy of immature permanent molars

the clinical and digital radiographic success of simvastatin versus MTA in pulpotomy of immature permanent molars for the following patients which include: Healthy children aged from 6 to 8 years who will be classified as Class I or II Children according to the American Society of Anaesthesiologists (ASA) will be included. Children with severe behavioral, or emotional disabilities, and medically compromised children will be excluded.

Inclusion Criteria:

• Healthy children aged from 6 to 8 years
• Children with severe behavioral, or emotional disabilities, and medically compromised children will be excluded.
• Deep carious lesions of the first permanent immature molars with signs & symptoms of reversible pulpitis will be included
• Normal radiographic findings and immature roots